NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP

Second mitochondria-derived activator of caspases (SMAC) mimetics is a class of new anticancer agents. However, most cancers exhibit de novo or acquired resistance to SMAC mimetics, posting a problem for broad applications in clinic, and highlighting the necessity of exploring combinational strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li, Yang, Guoshan, Bai, Hao, Zhang, Minghui, Mou, Dongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432304/
https://www.ncbi.nlm.nih.gov/pubmed/28460471
http://dx.doi.org/10.18632/oncotarget.15848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432304/
https://www.ncbi.nlm.nih.gov/pubmed/28460471
http://dx.doi.org/10.18632/oncotarget.15848

Ejemplares similares